Effects of clozapine on adipokine secretions/productions and lipid droplets in 3T3-L1 adipocytes.
J Pharmacol Sci
; 133(2): 79-87, 2017 Feb.
Article
en En
| MEDLINE
| ID: mdl-28209485
ABSTRACT
Clozapine, a second-generation antipsychotic (SGA), is a cause of side effects related to metabolic syndrome. The participation of serotonin 5-HT2C and histamine H1 receptors in the central nervous system has been reported as a mechanism of the weight gain caused by clozapine. In the present study, we investigated the direct pharmacological action of clozapine on the 3T3-L1 adipocytes and compared it to that of blonanserin, an SGA with low affinity for both receptors. Short-term exposure to clozapine decreased secretion and mRNA expression of leptin. Long-term exposure decreased leptin as well as adiponectin secretion, and further increased lipid droplets accumulation. However, short- and long-term exposures to blonanserin did not affect these parameters. A selective serotonin 5-HT2C, but not a histamine H1, receptor antagonist enhanced the decreased secretion of leptin induced by short-term exposure to clozapine, but did not affect the increased accumulation of lipid droplets. Our findings indicate that clozapine, but not blonanserin, strongly and directly affected the secretion of adipokines, such as leptin, in adipocytes and caused adipocyte enlargement.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Clozapina
/
Adipocitos
/
Leptina
/
Adiponectina
/
Gotas Lipídicas
Límite:
Animals
Idioma:
En
Año:
2017
Tipo del documento:
Article